Endocrine stress response and inflammatory activation during CABG surgery. A randomized trial comparing remifentanil infusion to intermittent fentanyl

European Journal of Anaesthesiology

Volumn 25, Issue 4, 2008, Pages 326-335

  Winterhalter, M ^a   Brandl, K ^a   Rahe Meyer, N ^a   Osthaus, A ^a   Hecker, H ^a   Hagl, C ^a   Adams, H A ^a   Piepenbrock, S ^a  

^a HANNOVER MEDICAL SCHOOL   (Germany)

Author keywords

Analgesics opioid, fentanyl, remifentanil; Cardiac surgery; Cardiopulmonary bypass; Endocrine system, stress response; Monitoring physiologic

Indexed keywords

ADRENALIN; ANTIARRHYTHMIC AGENT; ANTITHROMBOCYTIC AGENT; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; COMPLEMENT COMPONENT C3A; COMPLEMENT COMPONENT C5B; CORTICOSTEROID; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; FENTANYL; HYDROCORTISONE; INTERLEUKIN 6; INTERLEUKIN 8; NORADRENALIN; REMIFENTANIL; SEVOFLURANE; TROPONIN T; TUMOR NECROSIS FACTOR ALPHA; VASOPRESSIN;

ADRENALIN BLOOD LEVEL; ADULT; AGED; AORTA CLAMPING; ARTICLE; CARDIOPULMONARY BYPASS; CLINICAL TRIAL; CONTINUOUS INFUSION; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CORONARY ARTERY BYPASS GRAFT; DRUG DOSE REGIMEN; DRUG INTERMITTENT THERAPY; ENDOCRINE DISEASE; HORMONE RESPONSE; HUMAN; NORADRENALIN BLOOD LEVEL; RANDOMIZED CONTROLLED TRIAL; STERNOTOMY; SURGICAL STRESS;

ADRENOCORTICOTROPIC HORMONE; AGED; ANESTHETICS, INHALATION; ANESTHETICS, INTRAVENOUS; CORONARY ARTERY BYPASS; FEMALE; FENTANYL; HUMANS; HYDROCORTISONE; INFLAMMATION; INFUSIONS, INTRAVENOUS; INJECTIONS, INTRAVENOUS; INTERLEUKINS; MALE; METHYL ETHERS; MIDDLE AGED; PIPERIDINES; STRESS; TIME FACTORS; VASOPRESSINS;

EID: 40549084374     PISSN: 02650215     EISSN: 13652346     Source Type: Journal    
DOI: 10.1017/S0265021507003043     Document Type: Article

References (29)

1. Wallace AW. Is it time to get on the fast track or stay on the slow track? Anesthesiology 2003; 99: 774.
2. Slogoff S, Keats AS. Randomized trial of primary anesthetic agents on outcome of coronary artery bypass operations. Anesthesiology 1989; 70: 179-188.
3. Weale NK, Rogers CA, Cooper R, Nolan J, Wolf AR. Effect of remifentanil infusion rate on stress response to the pre-bypass phase of paediatric cardiac surgery. Br J Anaesth 2004; 92: 187-194.
4. Bell G, Dickson U, Arana A, Robinson D, Marshall C, Morton N. Remifentanil vs fentanyl/morphine for pain and stress control during pediatric cardiac surgery. Paediatr Anaesth 2004; 14: 856-860.
5. Matsumoto ED, Margulis V, Tunc L et al. Cytokine response to surgical stress: comparison of pure laparoscopic, hand-assisted laparoscopic, and open nephrectomy. J Endourol 2005; 19: 1140-1145.
6. Molina PE. Neurobiology of the stress response. Contribution of the sympathetic nervous system to the neuroimmune axis in traumatic injury. Shock 2005; 24: 3-10.
7. Gold SM, Mohr DC, Huitinga I, Flachenecker P, Sternberg EM, Heesen C. The role of stress-response systems for the pathogenesis and progression of MS. Trends Immunol 2005; 26: 644-652.
8. Rokutan K, Morita K, Masuda K et al. Gene expression profiling in peripheral blood leukocytes as a new approach for assessment of human stress response. J Med Invest 2005; 52: 137-144.
9. Brix-Christensen V. The systemic inflammatory response after cardiac surgery with cardiopulmonary bypass in children. Acta Anaesthesiol Scand 2001; 45: 671-679.
10. Ibrahim AE, Taraday JK, Kharasch ED. Bispectral index monitoring during sedation with sevoflurane, midazolam, and propofol. Anesthesiology 2001; 95: 1151-1159.
11. Ziegler MG, Lake CR, Kopin IJ. Plasma noradrenaline increases with age. Nature 1976 ; 261: 333-335.
12. Kuchel O, Buu NT. Circadian variations of free and sulfoconjungated catecholamines in normal subjects. Endocr Res 1985; 11: 17-25.
13. Saar N, Gordon RD. Variability of plasma catecholamine levels: age, duration of posture and time of day. Br J Clin Pharmacol 1979; 8: 353-358.
14. El-Etr AA, Glisson SN, Balasaraswathi K. Endocrine changes during anesthesia and cardiopulmonary bypass. Clev Clin Q 1981; 48: 132-138.
15. Tan CK, Glisson SN, El-Etr AA, Ramakrishnaiah KB. Levels of circulating norepinephrine and epinephrine before, during and after cardiopulmonary bypass in man. J Thorac Cardiovasc Surg 1976; 71: 928-931.
16. Reves JG, Karp RB, Buttner EE et al. Neuronal and adrenomedullary catecholamine release in response to cardiopulmonary bypass in man. Circulation 1982; 66: 49-55.
17. Laffey JG, Boylan JF, Cheng DC. The systemic inflammatory response to cardiac surgery: implications for the anesthesiologist. Anesthesiology 2002; 97: 215-252.
18. Rady MY, Ryan T, Starr NJ. Early onset of acute pulmonary dysfunction after cardiovascular surgery: risk factors and clinical outcome. Crit Care Med 1997; 25: 1831-1839.
19. Besedovsky HO, del Rey A. Immune-neuro-endocrine interactions: facts and hypotheses. Endocr Rev 1996; 17: 64-102.
20. Wan S, LeClerc JL, Vincent JL. Inflammatory response to cardiopulmonary bypass: mechanisms involved and possible therapeutic strategies. Chest 1997; 112: 676-692.
21. Ito H, Hamano K, Gohra H et al. Relationship between respiratory distress and cytokine response after cardiopulmonary bypass. Surg Today 1997; 27: 220-225.
22. Guggenberger H, Schroeder TH, Vonthein R, Dieterich HJ, Shernan SK, Eltzschig HK. Remifentanil or sufentanil for coronary surgery: comparison of postoperative respiratory impairment. Eur J Anaesthesiol 2006; 23: 832-840.
23. Yokoyama M, Itano Y, Katayama H et al. The effects of continuous epidural anesthesia and analgesia on stress response and immune function in patients undergoing radical esophagectomy. Anesth Analg 2005; 101: 1521-1527.
24. Soulika AM, Khan MM, Hattori T et al. Inhibition of heparin/protamine complex-induced complement activation by Compstatin in baboons. Clin Immunol 2000; 96: 212-221.
25. Seghaye MC, Duchateau J, Grabitz RG et al. Complement activation during cardiopulmonary bypass in infants and children. Relation to postoperative multiple system organ failure. J Thorac Cardiovasc Surg 1993; 106: 978-987.
26. Kirklin JK, Westaby S, Blackstone EH, Kirklin JW, Chenoweth DE, Pacifico AD. Complement and the damaging effects of cardiopulmonary bypass. J Thorac Cardiovasc Surg 1983; 86: 845-857.
27. Fitch JC, Rollins S, Matis L et al. Pharmacology and biological efficacy of a recombinant, humanized, singlechain antibody C5 complement inhibitor in patients undergoing coronary artery bypass graft surgery with cardiopulmonary bypass. Circulation 1999; 100: 2499-2506.
28. Voss EM, Sharkey SW, Gernet AE et al. Human and canine cardiac troponin T and creatine kinase-MB distribution in normal and diseased myocardium. Arch Pathol Lab Med 1995; 119: 799-806.
29. Wan S, Marchant A, DeSmet JM et al. Human cytokine responses to cardiac transplantation and coronary artery bypass grafting. J Thorac Cardiovasc Surg 1996; 111: 469-477.